The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease

Yong Eun Park; Jae Hee Cheon; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim

doi:10.1007/s10067-017-3904-2

The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease

Yong Eun Park, Jae Hee Cheon, Yehyun Park, Soo Jung Park, Tae Il Kim, Won Ho Kim

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet’s disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet’s disease. We retrospectively reviewed patients with intestinal Behçet’s disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908–0.982; P = 0.004), high disease activity index for intestinal Behçet’s disease score (adjusted OR, 1.111; 95% CI, 1.060–1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135–8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084–58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet’s disease.

Original language	English
Pages (from-to)	1913-1920
Number of pages	8
Journal	Clinical Rheumatology
Volume	37
Issue number	7
DOIs	https://doi.org/10.1007/s10067-017-3904-2
Publication status	Published - 2018 Jul 1

Bibliographical note

Funding Information:
Funding information This research was supported by a grant (A120176) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health and Welfare, Republic of Korea; a grant (NRF-2017R1A1A1A05001011) from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science, ICTand Future Planning; and a faculty research grant (2012-31-0477) from the Department of Internal Medicine, Yonsei University, College of Medicine.

Funding Information:
The authors are grateful to Dong-Su Jang, (medical illustrator, Medical Research Support Section, Yonsei University College of Medicine, Seoul, Republic of Korea) for his help with the figures. Jae Hee Cheon. This study was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and approved by the Institutional Review Board of Severance Hospital.

Publisher Copyright:
© 2017, International League of Associations for Rheumatology (ILAR).

All Science Journal Classification (ASJC) codes

Rheumatology

Access to Document

10.1007/s10067-017-3904-2

Cite this

@article{32e2e01a7d1d455eb3c0a0bcf72d0678,

title = "The outcomes and risk factors of early readmission in patients with intestinal Beh{\c c}et{\textquoteright}s disease",

abstract = "Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Beh{\c c}et{\textquoteright}s disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Beh{\c c}et{\textquoteright}s disease. We retrospectively reviewed patients with intestinal Beh{\c c}et{\textquoteright}s disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908–0.982; P = 0.004), high disease activity index for intestinal Beh{\c c}et{\textquoteright}s disease score (adjusted OR, 1.111; 95% CI, 1.060–1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135–8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084–58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Beh{\c c}et{\textquoteright}s disease.",

author = "Park, {Yong Eun} and Cheon, {Jae Hee} and Yehyun Park and Park, {Soo Jung} and Kim, {Tae Il} and Kim, {Won Ho}",

note = "Funding Information: Funding information This research was supported by a grant (A120176) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health and Welfare, Republic of Korea; a grant (NRF-2017R1A1A1A05001011) from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science, ICTand Future Planning; and a faculty research grant (2012-31-0477) from the Department of Internal Medicine, Yonsei University, College of Medicine. Funding Information: The authors are grateful to Dong-Su Jang, (medical illustrator, Medical Research Support Section, Yonsei University College of Medicine, Seoul, Republic of Korea) for his help with the figures. Jae Hee Cheon. This study was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and approved by the Institutional Review Board of Severance Hospital. Publisher Copyright: {\textcopyright} 2017, International League of Associations for Rheumatology (ILAR).",

year = "2018",

month = jul,

day = "1",

doi = "10.1007/s10067-017-3904-2",

language = "English",

volume = "37",

pages = "1913--1920",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "7",

}

TY - JOUR

T1 - The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease

AU - Park, Yong Eun

AU - Cheon, Jae Hee

AU - Park, Yehyun

AU - Park, Soo Jung

AU - Kim, Tae Il

AU - Kim, Won Ho

N1 - Funding Information: Funding information This research was supported by a grant (A120176) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health and Welfare, Republic of Korea; a grant (NRF-2017R1A1A1A05001011) from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science, ICTand Future Planning; and a faculty research grant (2012-31-0477) from the Department of Internal Medicine, Yonsei University, College of Medicine. Funding Information: The authors are grateful to Dong-Su Jang, (medical illustrator, Medical Research Support Section, Yonsei University College of Medicine, Seoul, Republic of Korea) for his help with the figures. Jae Hee Cheon. This study was performed in accordance with the ethical guidelines of the 1975 Declaration of Helsinki and approved by the Institutional Review Board of Severance Hospital. Publisher Copyright: © 2017, International League of Associations for Rheumatology (ILAR).

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet’s disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet’s disease. We retrospectively reviewed patients with intestinal Behçet’s disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908–0.982; P = 0.004), high disease activity index for intestinal Behçet’s disease score (adjusted OR, 1.111; 95% CI, 1.060–1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135–8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084–58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet’s disease.

AB - Hospital readmission rate is an integral quality of care measurement for hospitalized patients which is unknown for intestinal Behçet’s disease cases. The purpose of this study was to investigate the risk factors and outcomes for patients readmitted early with intestinal Behçet’s disease. We retrospectively reviewed patients with intestinal Behçet’s disease who were readmitted to our hospital between 2005 and 2016. We then analyzed the risk factors and outcomes for early readmission within 3 months. Of the 204 patients who were readmitted, 103 patients (50.5%) were readmitted within 3 months and 101 (49.5%) were never readmitted or readmitted after 3 months. After multivariate analysis, hospital stay at the first admission (adjusted odds ratio [OR], 0.945; 95% confidence interval [CI], 0.908–0.982; P = 0.004), high disease activity index for intestinal Behçet’s disease score (adjusted OR, 1.111; 95% CI, 1.060–1.165; P < 0.001), corticosteroid use (adjusted OR, 3.179; 95% CI, 1.135–8.910; P = 0.028), and opioid use (adjusted OR, 7.979; 95% CI, 1.084–58.755; P = 0.041) were independent factors for early readmission. We identified four independent prognostic factors for early readmission within 3 months, which might help guide appropriate management strategies for hospitalized patients with intestinal Behçet’s disease.

UR - http://www.scopus.com/inward/record.url?scp=85033382397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85033382397&partnerID=8YFLogxK

U2 - 10.1007/s10067-017-3904-2

DO - 10.1007/s10067-017-3904-2

M3 - Article

C2 - 29116542

AN - SCOPUS:85033382397

SN - 0770-3198

VL - 37

SP - 1913

EP - 1920

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 7

ER -

The outcomes and risk factors of early readmission in patients with intestinal Behçet’s disease

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this